| Hang Seng Index | 24.620 HKD | +0.100 | +0.408% | 693.36M | 17.23B | 23.260 (+5.848%) HKD as at 2025/02/25 | | |
| Hang Seng China Enterprises | 89.360 HKD | +0.600 | +0.676% | 162.60M | 14.63B | 86.975 (+2.742%) HKD as at 2025/02/25 | | |
| Hang Seng TECH Index | 5.150 HKD | +0.025 | +0.488% | 1.60B | 8.31B | 5.580 (-7.709%) HKD as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 4.996 HKD | +0.058 | +1.175% | 238.85M | 1.21B | 6.590 (-24.188%) HKD as at 2025/02/25 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.752 HKD | -0.020 | -1.129% | 566.13M | 975.63M | 1.831 (-4.335%) HKD as at 2025/02/25 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 2.180 HKD | -0.026 | -1.179% | 291.28M | 625.62M | 2.726 (-20.026%) HKD as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.340 HKD | +0.060 | +1.136% | 65.62M | 356.19M | 5.000 (+6.806%) HKD as at 2025/02/25 | | |
| Hang Seng TECH Index | 11.090 HKD | +0.080 | +0.727% | 19.29M | 215.22M | 12.133 (-8.594%) HKD as at 2025/02/24 | | |
| CSI Hong Kong Dividend | 37.080 HKD | -0.020 | -0.054% | 5.56M | 208.96M | 32.341 (+14.653%) HKD as at 2025/02/25 | | |
| Hang Seng TECH Index | 5.245 HKD | +0.035 | +0.672% | 32.16M | 170.08M | 5.659 (-7.308%) HKD as at 2025/02/25 | | |
| Hang Seng China Enterprises | 10.570 HKD | +0.030 | +0.285% | 10.31M | 109.28M | 10.808 (-2.205%) HKD as at 2025/02/24 | | |
| FTSE China A50 | 14.900 HKD | +0.170 | +1.154% | 6.73M | 99.95M | 13.749 (+8.372%) HKD as at 2025/02/24 | | |
| CSI 300 | 45.820 HKD | +0.060 | +0.131% | 1.93M | 88.86M | 43.473 (+5.398%) HKD as at 2025/02/25 | | |
| FTSE China A50 | 13.700 HKD | -0.030 | -0.218% | 4.88M | 67.63M | 12.681 (+8.033%) HKD as at 2025/02/25 | | |
| London Gold Fixing Price | 2,416.000 HKD | +16.000 | +0.667% | 21.86K | 52.71M | N/A | | |
| MSCI Asia APEX 50 | 63.280 HKD | -0.020 | -0.032% | 782.02K | 49.71M | 57.370 (+10.302%) HKD as at 2025/02/24 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 14.650 HKD | +0.860 | +6.236% | 2.82M | 40.96M | 11.063 (+32.426%) HKD as at 2025/02/25 | | |
| Hang Seng High Dividend Yield | 28.860 HKD | +0.060 | +0.208% | 798.28K | 23.14M | 24.714 (+16.775%) HKD as at 2025/02/24 | | |
| CME Bitcoin Futures | 40.100 HKD | +2.140 | +5.638% | 575.44K | 22.98M | 32.883 (+21.946%) HKD as at 2025/02/24 | | |
| CME Ether Futures | 14.270 HKD | +0.870 | +6.493% | 1.25M | 17.96M | 13.011 (+9.677%) HKD as at 2025/02/24 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 4.020 HKD | +0.042 | +1.056% | 4.14M | 16.58M | 4.925 (-18.381%) HKD as at 2025/02/24 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 14.080 HKD | +0.180 | +1.295% | 1.15M | 16.19M | 10.297 (+36.736%) HKD as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 3.810 HKD | +0.004 | +0.105% | 4.01M | 15.45M | 3.748 (+1.643%) HKD as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 3.290 HKD | +0.024 | +0.735% | 4.03M | 13.52M | 3.260 (+0.936%) HKD as at 2025/02/25 | | |
| FTSE US Treasury 20+ Years Index | 68.700 HKD | -0.120 | -0.174% | 188.79K | 12.98M | 70.043 (-1.917%) HKD as at 2025/02/24 | | |
| CSI China Reform Hong Kong Connect Central-SOEs High Dividend Yield Index | 9.565 HKD | +0.050 | +0.525% | 1.29M | 12.38M | 8.951 (+6.857%) HKD as at 2025/02/25 | | |
| CSI 300 | 41.840 CNY | 0.000 | 0.000% | 243.66K | 10.24M | 40.598 (+3.059%) CNY as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 17.060 HKD | +0.230 | +1.367% | 580.90K | 9.86M | 13.980 (+22.035%) HKD as at 2025/02/24 | | |
| London Gold Fixing Price | 79.180 HKD | +0.340 | +0.431% | 102.37K | 8.10M | 69.203 (+14.417%) HKD as at 2025/02/25 | | |
| CME CF Ether-Dollar Reference Rate - Asia Pacific Variant | 7.165 HKD | +0.440 | +6.543% | 959.40K | 6.87M | 5.740 (+24.832%) HKD as at 2025/02/25 | | |